Israeli Prime Minister Benjamin Netanyahu announced that he had prostate cancer and was undergoing targeted radiation therapy, as part of his annual health report, which was issued after a significant delay, which opened the door to questions about the timing of the announcement and the details of the treatment. According to the medical report issued by the Hadassah Center, according to Ynet, it was found that Netanyahu suffers from adenocarcinoma, which is the most common form of prostate cancer, accounting for about 95% of cases. The tumor was described as very small, not exceeding 0.9 cm in size, and without any spread to other organs, which places it among the low-risk cases. Doctors indicated that the discovery of the tumor came accidentally during an MRI examination conducted as part of a routine follow-up after a previous operation for benign prostate enlargement that Netanyahu underwent in late 2024. Successful treatment...and multiple options Faced with this diagnosis, Netanyahu was presented with two main options: active surveillance or radiotherapy. He chose radiotherapy, which was carried out about two and a half months ago, and subsequent examinations showed that the signs of the disease had disappeared, according to what the doctors confirmed. Prostate cancer is one of the most common types of cancer in men, especially after the age of fifty, and it is often discovered in the early stages without symptoms, which provides high chances of treatment. Despite the positive medical confirmations, Ynet states that there are still several ambiguities, most notably the type of radiotherapy used, the number of sessions, and whether it required general anesthesia. It was also not revealed whether Netanyahu suffered side effects, or whether an acting prime minister was appointed during the treatment period, in case that required legal proceedings. Also, the use of MRI in follow-up has raised questions, as the usual protocol after benign hyperplasia surgeries relies mainly on blood tests (PSA), which opens the door to the possibility of additional indicators that prompted this advanced examination. The timing of the announcement is a matter of controversy Netanyahu admitted that he requested to postpone the publication of his health report for about two months, justifying this by not coinciding with the war conditions, and to avoid what he described as exploiting the file in Iranian propaganda. However, this delay raised questions about transparency and timeliness of informing the public. What is this disease? Adenocarcinoma is a type of cancer that originates in glandular cells that secrete fluids inside the body, and it is the most common form in several organs such as the prostate, lung, and colon. In the case of the prostate specifically, adenocarcinoma is considered the most common among men. It often develops slowly and may not cause symptoms in its early stages, which makes it sometimes discovered by chance during routine examinations. Its seriousness varies according to its size and degree of spread, as it can remain limited for years without a significant impact, or in other cases it develops in a more aggressive manner. Treatment options depend on the stage of the disease, and include periodic monitoring, radiation therapy, surgery, and sometimes hormonal therapy, with high cure rates upon early diagnosis.